Sepracor Will Support Xopenex HFA Launch With Three Sales Forces
This article was originally published in The Pink Sheet Daily
Executive Summary
The firm will use two primary care sales forces and one specialty respiratory sales force to detail the hydrofluoroalkane metered-dose inhaler.